Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy
Harbin Medical University
Harbin Medical University
M.D. Anderson Cancer Center
MedSIR
Mayo Clinic
Istituti Clinici Scientifici Maugeri SpA
Rutgers, The State University of New Jersey
Institut Curie
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
Wake Forest University Health Sciences
City of Hope Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Centre Paul Strauss
Big Ten Cancer Research Consortium
Centre Jean Perrin
GBG Forschungs GmbH
University of Nebraska
Rutgers, The State University of New Jersey
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Kansas Medical Center
City of Hope Medical Center
Massachusetts General Hospital
Massachusetts General Hospital
Lund University Hospital
Virginia Commonwealth University
Cedars-Sinai Medical Center
Columbia University
Cancer Research UK
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of Illinois at Chicago
Icahn School of Medicine at Mount Sinai
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Peking University Cancer Hospital & Institute
Shanghai Junshi Bioscience Co., Ltd.
University of Chicago
Case Comprehensive Cancer Center
Washington University School of Medicine
University Health Network, Toronto
Fudan University
Baylor Breast Care Center
Providence Health & Services
Queen Mary University of London
City of Hope Medical Center
Centre Hospitalier Universitaire Vaudois
UNICANCER